For biologics, the reference product exclusivity under the BPCIA provides a 12-year market protection period that may extend beyond the CoM patent term
Thats because the skin can stretch during weight gain and doesnt always bounce back fully as elasticity decreases
Bottom line: Whether the FDA grants retatrutide priority review is genuinely uncertain and won't be known until after the BLA is submitted and accepted in 2027
Finally, compounded semaglutide is also an injection, but is not brand-name and does not come in single-use injector pens, and can be combined with other medications by the compounding pharmacy
Which one may or may not cause side effects for you will depend on your bodys individual response to either medication
Glutathione levels can be increased through intravenous glutathione, multivitamin, and alpha-lipoic acid (with doses and frequency varying by individual)